论文部分内容阅读
由中国医学科学院基础医学研究所与中国协和医科大学流行病学教研室、中国预防医学科学院全国疾病监测中心联合进行的调查结果表明,我国城乡乙肝疫苗接种取得显著成绩,实现卫生部制定的《全国乙肝疫苗接种实施方案》中期标准。 国内外研究证实,乙肝疫苗免疫后的人群HBsAg阳性率可明显降低,免疫后1～9年的疫苗保护率超过85％,乙肝疫苗接种已成为我国90年代以来控制乙肝的主要对策。为了解和掌握我国乙肝疫苗接种现状及其资料,调查组自1995年12月～1996年1月在美国中华医学基金会资助下,对北京、天津、上海等25个省、
The results of the survey carried out jointly by the Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences and the Department of Epidemiology, Peking Union Medical College and the National Disease Surveillance Center of Chinese Academy of Preventive Medicine showed that significant achievements have been made in the hepatitis B vaccination in urban and rural areas of our country and the “National Hepatitis B Vaccination implementation plan ”medium-term standards. Domestic and foreign studies have confirmed that the HBsAg positive rate of the population after hepatitis B vaccine immunization can be significantly reduced, vaccine protection rate of 1 to 9 years after immunization over 85%, hepatitis B vaccination has become the main countermeasure of hepatitis B control since the 1990s. In order to understand and grasp the status quo and information of hepatitis B vaccination in our country, from December 1995 to January 1996, the research team funded 25 Chinese provinces, including Beijing, Tianjin and Shanghai,